Why Meta Rejects Aesthetic Clinic Ads (and Why the ASA Would Object Too)
A rejection notice arrives naming a policy, and a clinic owner reasonably assumes that fixing it makes the advert compliant. It does not. Meta decides whether an advert may run on Meta. Whether it complies with UK advertising rules is a separate question, asked by a different body, usually after the advert has already been seen. This article sets out both, reason by reason, from the current primary pages.

Contents
- Direct answer
- Two gates, and neither one opens the other
- What Meta’s review actually is
- What Meta is looking for, reason by reason
- What the UK rules are looking for
- The same advert, seen by both
- Before and after: where the two gates plainly disagree
- Prescription-only medicines, and why a different word does not settle it
- When an advert is rejected
- Before you publish
- When to take advice, and what this article is not
- How Outcome Reach handles this
- Sources
Two gates, and neither one opens the other
A rejection arrives as a short notice naming a policy. It gives a clinic owner one piece of information, which is that Meta will not run this advert as written. It is routinely read as a second thing, which is that the advert was not allowed, and a third, which is that fixing the stated reason makes the advert compliant. Neither of those follows.
There are two separate systems applying two separate tests, run by two organisations applying different rules.
The two gates
- Meta’s ad review
- A private company applying its own Advertising Standards to decide whether an advert may run on its platforms. It happens before the advert goes live, primarily by automated tools, and it can happen again at any time afterwards. Failing it means the advert is rejected, and the account behind it may be restricted.
- The UK advertising rules
- The CAP Code, administered by the Advertising Standards Authority, alongside statute such as the Human Medicines Regulations 2012, which the Code’s medicines rules reflect. These apply to the advert whether or not any platform reviewed it, and they are applied after it has appeared, when somebody complains or the ASA’s own monitoring finds it. Failing them means a ruling and, for a prescription-only medicine, a matter of medicines law rather than of a code.
This is not our interpretation of Meta’s position. It is Meta’s stated position. Its Advertising Standards say that its policies "require all advertisers to comply with the laws in their jurisdiction", and that it is the advertiser’s responsibility to comply with Meta’s policies "in addition to all local laws, regulations and, where applicable, self-regulatory advertising codes". The CAP Code is exactly such a code. Meta is telling advertisers that passing its review is not a finding that the advert complies with local law.
The two gates also happen at different moments, which is why passing the first one feels like an all clear and is not.
- WrittenThe clinic makes the advert
- Meta reviewBefore it runs, against Meta’s policies
- LiveApproved, and seen by the public
- Complaint or monitoringAfter it has run, if at all
- ASA assessmentAgainst the CAP Code, after the fact
By the time the second gate is reached, the advert has already run. That is the practical reason a clinic has to apply the UK rules itself, before publication, rather than treating approval as the test.
What Meta’s review actually is
Meta describes a review system that "relies primarily on automated tools to check ads and business assets against our policies", that starts automatically before ads run and is "typically completed within 24 hours". It states that the review "may include the specific components of an ad, such as images, video, text and targeting information, as well as an ad’s associated landing page or other destinations". So the destination can be part of what is assessed, not a separate thing beyond the platform’s reach.
Three consequences follow, and all three are in Meta’s own text rather than in ours.
- Approval is not permanent. Meta states that "ads remain subject to review and re-review at all times, and may be rejected or restricted for violation of our policies at any time". An advert that ran for months can be rejected tomorrow.
- Rejection is not the only outcome. A violation can also restrict the Business Account or its assets, meaning the ad account, Page or user account, and a restricted asset cannot be used to advertise. Meta also notes that "lower-quality ads that do not necessarily violate our policies may experience an impact on performance", which is a third thing again and looks like nothing at all from the inside.
- Nobody can promise you approval. Meta reserves "the right to reject, approve or remove any ad for any reason, at our sole discretion". Any provider who promises that an advert will be approved, and that includes us, is describing something outside their control.
None of that tells you anything about UK compliance, because none of it is asking that question.
What Meta is looking for, reason by reason
These are the standards that bear on aesthetic clinic advertising. The wording is Meta’s, read from the current policy pages on 20 September 2026, and it changes: the health and wellness page alone carries a change log entry from July 2026.
The advert says something about the reader
The privacy violations and personal attributes standard prohibits content that "asserts or implies personal attributes". The listed attributes include age and "physical or mental health (including medical conditions)". Meta’s stated preference is the alternative: "ads should focus on the benefits of the product or service being advertised", and "you/your" language is allowed as long as it does not reference a personal attribute.
Meta publishes its own examples. Under age, it treats a line written about what a wrinkle cream does as acceptable, and "Ready to upgrade your skin to look younger?" as not. The pattern is the useful thing: a sentence about the treatment is acceptable under this standard, and the same idea rewritten as a question about the reader is not. That is one standard among several, and it says nothing about the rest of the advert.
The advert attacks an appearance
This one is easy to attribute to the personal attributes standard, and it is worth being precise, because the fix is different. Appearance as such is not one of the listed personal attributes. The rule that catches it sits in the health and wellness standard, which prohibits ads promoting cosmetic products or procedures that contain "statements of inferiority about physical appearance", defined there as "terms, descriptions or questions that are negative and attack an individual’s appearance, specific body parts or hygiene".
Body contouring and skin advertising are exposed to this, because the plain language of those treatments is close to the language of the rule. Describing what the procedure does is not what this standard prohibits; describing what is wrong with the reader is.
The advert promises a result, or a timescale
The same standard prohibits ads that "employ clickbait tactics in a health, weight loss or weight gain context, such as sensational language with exaggerated or extreme claims, or promises of specific outcomes within a set time frame without disclaimers or qualifiers".
The advert is not restricted to adults
The health and wellness standard requires that "ads promoting or marketing cosmetic products, procedures or surgeries must be targeted to people aged at least 18 years or older". This is a targeting setting rather than a wording problem, and it is easy to leave wrong.
The imagery reads as adult content
The adult nudity and sexual activity standard prohibits adverts that "depict nudity even where otherwise permitted or restricted by the Community Standards or near nudity". Separately, it says that imagery "focused on individual body parts, such as groin, buttock or female breast(s)", and imagery "depicting female nipples in medical, health or breastfeeding contexts", should be targeted above the age of 18. The same standard says Meta makes "certain exceptions in ads related to art and health", and it treats medical and health imagery as something to age-target rather than to ban. Clinical photography of a treatment area is therefore not automatically outside the rules, and not automatically inside them either.
The advert promotes a prescription medicine
Meta permits prescription medicine advertising only from advertisers certified with LegitScript or cleared through its internal review, with written authorisation, and only targeting "people in eligible countries (United States, Canada or New Zealand)". The United Kingdom is not among them. A UK clinic therefore cannot run an advert that promotes a prescription medicine on Meta. That is a platform decision about where such adverts may be targeted, and it is not the same thing as the UK legal position, which is set out below and is the one that carries legal consequences.
The destination does not match the advert
Meta states that "the products and services promoted in an ad must match those promoted on the landing page", and that the landing page may form part of what is reviewed. A treatment advert pointing at a homepage offering everything is a weaker advert for ordinary reasons, and it is also a policy question.
What the UK rules are looking for
The UK side is asking a different question: not whether the advert may appear on a platform, but whether it misleads, whether it is socially responsible, and whether it advertises something that may not be advertised to the public at all.
Four points are the ones we check first.
- Evidence has to exist first. CAP rule 3.7 requires that "before distributing or submitting a marketing communication for publication, marketers must hold documentary evidence" for claims consumers regard as objective. The timing is part of the rule: the evidence must exist before the advert is submitted, and the rule adds that the ASA may regard a claim as misleading in the absence of adequate substantiation. Holding a document is not the same as holding adequate evidence for the claim as worded.
- Rule 3.1 prohibits marketing communications that "materially mislead or be likely to do so", and rule 3.9 prohibits misleading "by omitting significant limitations and qualifications". A qualification that contradicts the claim it qualifies does not rescue the claim.
- Prescription-only medicines and prescription-only medical treatments "may not be advertised to the public" (rule 12.12), and cosmetic interventions advertising "must not be directed at those aged below 18 years through the selection of media or context in which they appear" (rule 12.25).
- CAP’s advice on non-surgical cosmetic procedures asks marketers to "ensure that their ads are responsible", to "hold evidence for all claims of efficacy", not to "exploit insecurities", and not to "trivialise the procedure". It adds that promotions are not prohibited, but "the promotion must be responsible and never should pressure those seeing the ad into booking, even if the procedure is minimally or non-invasive".
One point of scope surprises people. The CAP Code is not limited to paid advertising. Its scope expressly covers marketing communications by companies "on their own websites, or in other non-paid-for space online under their control". A clinic’s own treatment page, being directly connected with the supply of the service, is inside the Code whether or not any advert ever pointed at it.
Above the Code sits the law. Regulation 284 of the Human Medicines Regulations 2012 provides that "a person may not publish an advertisement that is likely to lead to the use of a prescription only medicine". That is a statutory prohibition, not a code of practice, and its test is the likely effect of the advertisement rather than the words chosen.
The same advert, seen by both
This table is the article. The left and middle columns are what each system is looking for, sourced as above. The right column is ours: the question we ask on our own gate before an advert is submitted.
| Issue | What Meta’s review is looking for | What the UK rules are looking for | What to check before you publish |
|---|---|---|---|
| How the reader is addressed | Whether the advert asserts or implies a personal attribute, including age or health. "You/your" is allowed without one. | Whether the advert is socially responsible and does not exploit insecurities (CAP advice on non-surgical procedures). | Rewrite every sentence to be about the treatment or the consultation. If a line only works as a question about the reader, rewrite it. |
| Appearance and insecurity | Statements of inferiority about physical appearance, meaning wording that attacks an appearance, a body part or hygiene. | The same conduct, reached through social responsibility and the requirement not to exploit insecurities. | Read the advert as the least confident person who will see it. If it makes the reader the problem, change it. |
| Claims of efficacy | Exaggerated or extreme claims, and promises of specific outcomes within a set time frame without qualifiers. | CAP 3.1 and 3.7: the claim must not mislead, and documentary evidence must be held before the advert is submitted. | For every claim, identify the evidence you hold and whether it supports the claim as worded. If you cannot do that today, the claim does not run today. |
| Offers with a deadline | On the Meta pages reviewed on 20 September 2026, no standard was identified that prohibits a time-limited offer in itself. | CAP advice is explicit that a promotion must never pressure those seeing the advert into booking. | Do not read platform approval as an answer to this; it is a UK question whatever Meta’s position. Treat countdowns and expiring prices as a compliance question, not a marketing one. |
| Prescription-only medicines | Ads promoting prescription medicines are limited to certified advertisers targeting the United States, Canada or New Zealand, so a UK clinic cannot run one. | Regulation 284 prohibits publishing an advertisement likely to lead to the use of a prescription-only medicine. CAP 12.12 says such treatments may not be advertised to the public. | Ask what the advert as a whole is likely to lead to, not which words it contains. See the section below. |
| Before-and-after imagery | Permitted for general cosmetic procedures when the advert is targeted to people aged 18 or over. | An image is a claim: CAP 3.7 requires evidence held first, and where the pictured client received a prescription-only medicine, CAP says the image is likely to be seen as an ad for it. | Platform permission is not evidence. Ask whether the result is typical, whether you hold proof, and what treatment produced it. |
| Age targeting | Cosmetic products, procedures and surgeries must be targeted to people aged at least 18. | CAP 12.25: cosmetic interventions advertising must not be directed at under-18s through the selection of media or the context in which it appears. | Set the age floor, then ask the second question the Code asks: is the placement and the context itself aimed at a young audience? |
| Imagery of the body | No nudity or near nudity. Imagery focused on individual body parts should be targeted to over-18s. | Social responsibility and not exploiting insecurities (CAP advice); no imagery-specific UK rule was identified on the pages reviewed. | Prefer the treatment being delivered or the practitioner to a body part in isolation; the standard still applies to whatever is shown. |
| The destination page | The products and services in the advert must match the landing page, and the destination may be reviewed with the advert. | The Code covers the clinic’s own website as well as the advert, so the page is assessed on the same rules. | Apply every check on this table to the landing page too. It is not outside either system. |
Before and after: where the two gates plainly disagree
This is the clearest illustration on the page, and it catches experienced advertisers out. Meta’s health and wellness standard, when targeting people aged 18 or older, expressly lists what advertisers can run, and that list includes "general cosmetic products, procedures, operations depicting before-and-after transformation". Read on its own, that is permission.
It is permission under that one standard, for that element of the advert, and Meta’s other standards still apply. It is not evidence, which is what the UK side wants. A before-and-after image makes a claim about what the treatment does, which puts it inside CAP rule 3.7: the documentary evidence has to be held before the advert is submitted. It raises rule 3.9, because a result that is not typical needs a qualification that does not contradict it. CAP’s own guidance adds two things: such images need signed and dated proof that they are genuine and representative of what can be achieved, and an image of a client who received a prescription-only medicine is likely to be seen as an advertisement for it, which takes it into regulation 284 territory rather than a code question.
So the answer to "can I show a before and after" is that Meta’s health and wellness standard does not forbid it, and that is not the question you needed answered.
Prescription-only medicines, and why a different word does not settle it
Some of the best known treatments in aesthetics are prescription-only medicines. Two separate UK provisions apply, and they carry legal rather than commercial consequences.
Regulation 284 of the Human Medicines Regulations 2012 provides that "a person may not publish an advertisement that is likely to lead to the use of a prescription only medicine". CAP rule 12.12 provides that "prescription-only medicines or prescription-only medical treatments may not be advertised to the public". Note what the statutory test is attached to: the likely effect of the advertisement. It is not attached to a list of forbidden words, which is why swapping a word cannot be relied on to answer it.
CAP has published its own position on indirect and implied references, and it makes the point better than a paraphrase can. In its guidance, a clinic that offers only prescription-only treatments is advised against a common descriptive substitute because it is "likely to be seen as an implied ad for a ‘prescription-only medicine’", while the same phrase may be acceptable for a clinic that genuinely offers non-prescription treatments as well. The identical words change status depending on what the clinic actually provides and what the rest of the advert implies. CAP also treats price promotions on these treatments as unlikely to be acceptable even on a clinic’s own website, because the focus has moved from a consultation to the product.
The ASA has applied this to an advert that never named a medicine. In a ruling of 18 December 2024, a paid social advert offering "cosmetic injections" for three areas at a price was read alongside the clinic’s own website, which showed that offer applied to its anti-wrinkle treatments; because those were botulinum toxin injections, the advert was held to have advertised a prescription-only medicine indirectly. The words were generic. What the clinic actually offered, and what a reader would understand, decided it.
When an advert is rejected
A rejection is a decision about one advert against one policy. Work through it in that order, and keep the UK question separate, because the rejection did not answer it.
Read the policy it names, on the policy page
The notice names a standard. Open that standard on Meta’s Transparency Centre and read what it actually prohibits, which can be narrower or wider than the name suggests. It is easy to attribute a rejection to the wrong policy, and the wrong policy leads to the wrong fix.
Decide which of two situations you are in
Either the advert does fall outside the policy as written, or you believe the decision was wrong. These lead to different actions, and it is worth being honest about which one you are in.
If the advert falls outside the policy, change the advert
Not the image crop, not the placement, not the wording around it: the thing the policy objects to. Meta states that edited adverts are treated as new adverts and are reviewed again. Resubmitting something that does breach a policy is not a route through, and Meta says it monitors and investigates advertiser behaviour and may restrict accounts that do not follow its standards.
If you believe the decision was wrong, use the published route
Meta’s stated process is that if you think an advert, ad account, Page or Business Account was incorrectly rejected or restricted, you can request a review of the decision in Account Quality. That is the mechanism the platform provides, and it is the only one worth using.
Ask the UK question separately, and answer it yourself
Take the same advert through the table above. A rejection tells you nothing about whether the advert would have complied with the CAP Code, and an approval after your edit tells you nothing either.
If the account is restricted rather than the advert, treat it as a different problem
A restricted Business Account or asset cannot be used to advertise at all, and it is a decision about the account, not about one piece of creative. It has its own review route in Account Quality, and rebuilding elsewhere is not a remedy.
Before you publish
This is our own pre-publication gate rather than anybody’s official checklist. It is ordered the way faults actually appear.
Before you publish
- Every sentence describes the treatment, the consultation or the practitioner, and none of them describes the reader.
- Nothing in the copy or imagery attacks an appearance, a body part or a perceived flaw.
- Every claim of efficacy has evidence behind it that you could produce today, that supports the claim as worded, and that existed before the advert was submitted, not after.
- Any result shown or implied is qualified where it is not typical, and the qualification does not contradict the claim.
- There is no countdown, expiring price or other pressure to book, on the advert or the page.
- No prescription-only medicine is named, pictured or implied, and the advert as a whole is not likely to lead to the use of one. If the advert only makes sense because the reader knows which medicine you mean, it fails.
- Age targeting is set to 18 or over, and the placement and context are not themselves aimed at a younger audience.
- Imagery shows the treatment or the practitioner rather than an isolated body part, and contains no nudity or near nudity.
- The landing page matches the advert, and passes every line of this list itself.
- Somebody other than the person who wrote the advert has read it against this list, and the result is written down before the advert is submitted.
When to take advice, and what this article is not
Two routes are open to any clinic and are underused. CAP operates a Copy Advice service for non-broadcast marketing, which will look at specific wording before it runs, and CAP’s AdviceOnline pages are written for this sector and updated regularly. Where a treatment involves a prescription-only medicine, the question has left advertising and entered medicines regulation, and it is worth professional advice rather than a reading of a guidance page.
How Outcome Reach handles this
As a statement of our method rather than evidence of an outcome: nothing is submitted until it has been through a written gate, which is the checklist above with the clinic’s own evidence attached to each claim, and the result is recorded before spend. We do not treat platform approval as the test, because it is not one, and we hold adverts rather than guess when a claim is uncertain. Our approach to compliance sets out how that sits in the wider system.
For campaign construction and measurement rather than the rules, the Meta ads guide is the stage pillar. For substantiation worked through one treatment, how to get more laser hair removal clients. For the chain all of this sits inside, how to get more clients for an aesthetics business.
Sources
- Meta Advertising Standards States that each ad is reviewed against Meta’s policies, that review is primarily automated and typically completed within 24 hours, that it may include the ad’s landing page or other destinations, that ads remain subject to re-review at any time, and that advertisers must comply with all local laws, regulations and, where applicable, self-regulatory advertising codes.Meta Transparency Centre · Read 20 September 2026
- Privacy violations and personal attributes Prohibits ads that assert or imply personal attributes, a list that includes age and physical or mental health. Says ads should focus on the benefits of the product or service and may use “you/your” language without a personal attribute. Carries Meta’s own acceptable and unacceptable examples.Meta Transparency Centre · Read 20 September 2026; change log entry 26 June 2024
- Health and Wellness Requires ads for cosmetic products, procedures or surgeries to be targeted to people aged at least 18. Prohibits statements of inferiority about physical appearance and clickbait tactics including promises of specific outcomes within a set time frame without disclaimers or qualifiers. Lists, for ads targeted to adults, permitted cosmetic categories and “General cosmetic products, procedures, operations depicting before-and-after transformation”.Meta Transparency Centre · Read 20 September 2026, re-rendered 23 September 2026; change log entry 23 July 2026
- Drugs and pharmaceuticals Ads promoting prescription medicines require LegitScript certification or Meta’s internal review, written authorisation from Meta, and may only target people in the United States, Canada or New Zealand.Meta Transparency Centre · Read 20 September 2026
- Adult nudity and sexual activity Ads must not depict nudity or near nudity. Imagery focused on individual body parts, and imagery depicting female nipples in medical or health contexts, should be targeted above the age of 18.Meta Transparency Centre · Read 20 September 2026
- CAP Code, Scope of the Code Paragraph (h) brings within the Code marketing communications by companies, organisations or sole traders on their own websites, or in other non-paid-for space online under their control, that are directly connected with the supply of goods or services.Committee of Advertising Practice · Read 20 September 2026
- CAP Code section 3, Misleading advertising Rule 3.1 marketing communications must not materially mislead. Rule 3.7 marketers must hold documentary evidence before distributing or submitting a marketing communication for publication. Rule 3.9 must not mislead by omitting significant limitations and qualifications.Committee of Advertising Practice · Read 20 September 2026
- CAP Code section 12, Medicines, medical devices, health-related products and beauty products Rule 12.12 prescription-only medicines or prescription-only medical treatments may not be advertised to the public. Rule 12.25 marketing communications for cosmetic interventions must not be directed at those aged below 18 through the selection of media or context.Committee of Advertising Practice · Read 20 September 2026
- Cosmetic Interventions: Non-surgical procedures Marketers should ensure ads are responsible, hold evidence for all claims of efficacy, not exploit insecurities, and not trivialise the procedure. Promotions are not prohibited but must never pressure those seeing the ad into booking.CAP AdviceOnline · Read 20 September 2026
- Frequently asked questions on advertising a prescription-only injectable treatment CAP’s position on indirect and implied references to a prescription-only medicine, including that a substituted term may still be read as an implied advertisement depending on what the clinic actually offers, and that references must be incidental, balanced and factual with the consultation as what is advertised.CAP News, 23 January 2020 · Read 20 September 2026
- ASA ruling: Valterous Ltd t/a Therapie Clinic A social media ad offering a price for a number of treatment areas was held to refer to anti-wrinkle treatments and so to advertise a prescription-only medicine indirectly. The ad was told not to appear again in that form.Advertising Standards Authority · 18 December 2024
- The Human Medicines Regulations 2012, regulation 284 “A person may not publish an advertisement that is likely to lead to the use of a prescription only medicine”, subject to narrow exceptions for approved vaccination and pathogen campaigns.legislation.gov.uk · Read 20 September 2026



